| 06/08 | WESANA HEALTH CEO DANIEL CARCILLO TO : Re-Imagining Substance Abuse, Addiction, and Mental.. | AQ |
| 05/31 | Wesana Announces First Quarter 2022 Financial Results | AQ |
| 05/31 | Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairm.. | CI |
| 05/30 | Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March .. | CI |
| 05/10 | Wesana Health Outlines Accelerated Drug Development Pathway | AQ |
| 05/10 | Wesana Health Holdings Outlines Accelerated Drug Development Pathway | CI |
| 05/05 | Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its.. | AQ |
| 05/05 | Wesana Health Holdings Announces Review of Strategic Alternatives of its Clinics and Ot.. | CI |
| 05/02 | Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highligh.. | AQ |
| 05/02 | Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 3.. | CI |
| 04/27 | Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th | AQ |
| 04/19 | Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disor.. | AQ |
| 04/18 | Wesana Explores Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder | CI |
| 04/18 | Wesana Health Holdings Inc. announced that it expects to receive CAD 3.7854 million in .. | CI |
| 03/29 | Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Eve.. | AQ |
| 03/23 | Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Ant.. | AQ |
| 03/22 | Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Ant.. | AQ |
| 03/14 | Wesana Health Up 25% As Announces Positive Feedback From Pre-IND Meeting With FDA on SA.. | MT |
| 03/14 | WESANA HEALTH BRIEF : Up Near 25% As Announces Positive Feedback From Pre-IND Meeting With.. | MT |
| 03/14 | Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013 | AQ |
| 03/14 | Wesana Health Holdings Announces Feedback from Pre-IND Meeting with Food and Drug Admin.. | CI |
| 03/11 | Wesana Provides Updates on Build-out of Third Clinic | AQ |
| 03/11 | Wesana Provides Updates on Build-Out of Third Clinic | CI |
| 01/25 | Wesana Health Holdings Appoints Meghna A. Gaeta as Chief Marketing Officer | CI |
| 01/25 | Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer | GL |
| 01/18 | Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatme.. | AQ |
| 01/18 | Wesana Health Announces Positive Findings from Animal Study on Novel Depression Treatme.. | CI |
| 01/12 | Wesana Health Holdings Inc. Announces Executive Changes | CI |
| 01/12 | Wesana Health Provides Strategic and Operational Updates | GL |
| 01/12 | Wesana Health Holdings Inc. Announces Resignation of Israel Mirsky, Chief Marketing and.. | CI |
| 01/11 | Wesana Health Granted US FDA Pre-IND Meeting for SANA-013 | GL |
| 01/11 | Wesana Health Holdings Inc. Grants US FDA Pre-IND Meeting for SANA-013 | CI |
| 2021 | MAPS and Wesana Health Resume Negotiations | AQ |
| 2021 | Wesana Health Holdings Inc. Files Patent Cooperation Treaty Patent Applications Towards.. | CI |
| 2021 | Wesana Completes Filing of PCT Patents for Novel Drug Protocols | GL |
| 2021 | Wesana Health Reports Q3 2021 Financial Results | GL |
| 2021 | Wesana Health Holdings Inc. acquired Advanced Psychiatric Management LLC. | CI |
| 2021 | Wesana Health Clinics Crosses 4,000 Administered Ketamine Treatments | MT |
| 2021 | Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments | AQ |
| 2021 | KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie.. | AQ |
| 2021 | KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th | AQ |
| 2021 | WESANA HEALTH : Announces Inclusion in the AdvisorShares Psychedelics ETF | GL |
| 2021 | WESANA HEALTH : Commits Funding of $1.5 Million To Support MAPS' Research Pipeline | AQ |
| 2021 | Wesana Health Commits Funding of $1.5 Million To Support MAPS' Research Pipeline | GL |
| 2021 | Wesana Health Holdings Inc. Announces Executive Changes | CI |
| 2021 | WESANA HEALTH : Announces Closing of PsyTech Acquisition | AQ |
| 2021 | Wesana Health Holdings Inc. completed the acquisition of PsyTech Inc. | CI |
| 2021 | WESANA HEALTH : Distinguished Psychedelic Researcher, Professor of Psychiatry and Neurosci.. | AQ |
| 2021 | Wesana Health Holdings Inc. Appoints Rachel Yehuda, as Scientific Advisory Board | CI |
| 2021 | WESANA HEALTH : Early Warning News Release | GL |
| 2021 | Wesana Health Highlights Recent Appointments to Board of Directors | GL |
| 2021 | Wesana Health Holdings Inc. Announces Board Appointments | CI |
| 2021 | WESANA HEALTH : Commences Functional Animal Study for Treatment of Traumatic Brain Injury | AQ |
| 2021 | WESANA HEALTH : Commences Functional Animal Study for Treatment of Traumatic Brain Injury | AQ |
| 2021 | Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury | CI |
| 2021 | WESANA HEALTH : Announces listing on otcqb venture market | AQ |
| 2021 | WESANA HEALTH : Ian Burnstein Joins Wesana Health Board of Directors | AQ |
| 2021 | Wesana Health Holdings Inc. Appoints Ian Burnstein to its Board of Directors | CI |
| 2021 | WESANA HEALTH : Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The.. | AQ |
| 2021 | WESANA HEALTH : Ian Burnstein Joins Wesana Health Advisory Board | AQ |
| 2021 | Ian Burnstein Joins Advisory Board of Wesana Health Holdings Inc | CI |
| 2021 | WESANA HEALTH : to Acquire PsyTech Inc. For $21 Million in All-Share Deal | MT |
| 2021 | WESANA HEALTH : IIROC Trade Resumption - WESA | AQ |
| 2021 | WESANA HEALTH : IIROC Trading Halt - WESA | AQ |
| 2021 | Wesana Health Holdings Inc. entered into a definitive agreement to acquire PsyTech Inc... | CI |
| 2021 | WESANA HEALTH : Partners with University of South Carolina | AQ |
| 2021 | Wesana Health Holdings Inc. Announces A Partnership with the University of South Caroli.. | CI |
| 2021 | Wesana Health Holdings Inc. Appoints James Fadiman to Scientific Advisory Board | CI |
| 2021 | Wesana Health Expands Research Leadership Team with Mark Wingertzahn as Chief Scientifi.. | CI |
| 2021 | WESANA HEALTH : The World Boxing Council and Wesana Health Announce Multi-Year Joint Effor.. | AQ |
| 2021 | The World Boxing Council and Wesana Health Holdings Inc. Announce Multi-Year Joint Effo.. | CI |
| 2021 | Wesana Health Holdings Inc. Appoints George Steinbrenner IV to its Board of Directors | CI |
| 2021 | Made Therapeutics, Inc. announced that it has received $4.109 million in funding | CI |
| 2021 | Made Therapeutics, Inc. announced that it expects to receive $4.109 million in funding | CI |
| 2021 | Made Therapeutics, Inc. announced that it expects to receive CAD 15 million in funding | CI |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
